Ketone Monitoring in T1D: Effect of SGLT2i During Usual Care and With Insulin Deficiency
Status:
Not yet recruiting
Trial end date:
2024-08-31
Target enrollment:
Participant gender:
Summary
This proposed study will test whether measurement of breath acetone (BrAce) can be used for
the purpose of identifying ketosis (elevated ketones) in persons with type 1 diabetes (T1D).
This is important for the potential use of sodium glucose co-transport inhibitors (SGLT2i) in
persons with T1D.